Author:
Katlan Danyah,Hasan Hani,Aseeri Mohammed,Alsubhi Abrar,Ismail Sherin
Abstract
Abstract
Background
Limited data are available regarding the prevalence of medication-related problems (MRPs) in kidney transplant recipients. This study aimed to determine the prevalence and types of medication-related problems.
Methods
A cross-sectional study was conducted including kidney transplant recipients aged ≥ 18 years who were receiving immunosuppressive agents for at least 3 months post-transplant. The primary outcome was to determine the prevalence of MRPs. The secondary outcomes were to identify the pharmacological classes, categories of medications contributing to MRPs, and predictors of developing > 3 MRPs.
Results
We enrolled 107 kidney transplant recipients. The mean ± standard deviation (SD) of age and body mass index (BMI) were 50 ± 15.8 years and 28.9 ± 5.3 (kg/m2), respectively, and 66.3% were male. The prevalence of MRPs was 28.97% [95% confidence intervals (CI) 19.68%, 41.125] in 1393 prescriptions. The frequent types of MRPs were drug‒drug interactions (46.1%), duplication (12%), and medication use without an indication (11.7%). Immunosuppressive agents and cardiac medications were the main classes causing MRPs. The number of medications and the years post-kidney-transplant were significant predictors of developing > 3 MRPs.
Conclusion
The results showed that drug‒drug interactions were the most frequent MRPs, with immunosuppressive agents being the most common class causing MRPs.
Publisher
Springer Science and Business Media LLC
Reference35 articles.
1. Luyckx VA, Tonelli M, Stanifer JW. The global burden of kidney disease and the sustainable development goals. Bull World Health Org. 2018;96(6):414-422D.
2. Center for Disease Control and Prevention. Chronic Kidney Disease in the United States, 2019. https://www.cdc.gov/kidneydisease/publications-resources/2019-national-facts.html; [accessed 23 September 2020].
3. Annual Report for Organ Transplantation in Kingdom of Saudi Arabia 2017. http://www.scot.gov.sa/images/Report_En_F_annual%20report%202017.pdf; [accessed 19 September 2020].
4. Repp KL, Hayes C 3rd, Woods TM, Allen KB, Kennedy K, Borkon MA. Drug-related problems and hospital admissions in cardiac transplant recipients. Ann Pharmacother. 2012;46(10):1299–307.
5. Manitpisitkul W, McCann E, Lee S, Weir MR. Drug interactions in transplant patients: what everyone should know. Curr Opin Nephrol Hypertens. 2009;18(5):404–11.